OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Prevention and Management of Delirium in the Intensive Care Unit	51
Cutaneous Sarcoidosis	41
Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment	34
Staphylococcus aureus Pneumonia in the Community	33
Ocular Sarcoidosis	31
Vasopressor Therapy in the Intensive Care Unit	27
Lymphangioleiomyomatosis	25
Artificial Intelligence in the Intensive Care Unit	24
FeNO in Asthma	23
Q Fever (Coxiella Burnetii)	23
Determinants and Management of the Post–Pulmonary Embolism Syndrome	23
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia	22
Hermansky–Pudlak Syndrome	22
Cardiac Sarcoidosis	21
Management and Challenges of Severe Traumatic Brain Injury	20
What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock?	20
Nocardia spp.: A Rare Cause of Pneumonia Globally	19
Advanced Pulmonary Sarcoidosis	19
Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome	19
Physiological and Pathophysiological Consequences of Mechanical Ventilation	19
Pathophysiology of Bronchiectasis	17
Monitoring Lung Injury Severity and Ventilation Intensity during Mechanical Ventilation	17
COVID-19 and Its Implications for Thrombosis and Anticoagulation	16
Obesity and Asthma	15
The Lung Allocation Score and Its Relevance	14

Primary Ciliary Dyskinesia	14
Pulmonary Langerhans Cell Histiocytosis	13
Pulmonary Alveolar Proteinosis Syndrome	12
Sarcoidosis-Associated Pulmonary Hypertension	12
Elderly Patients in the Intensive Care Unit	12
Health-Related Quality of Life in Sarcoidosis	12
Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus	12
Physical Therapy and Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit	11
Hepatic Sarcoidosis: Current Concepts and Treatments	11
Lung Cancer Screening	11
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future	11
Severe Infections Due to Respiratory Viruses	10
Targeted Therapy for Non-Small Cell Lung Cancer	10
New Developments in the Pathogenesis of Pulmonary Cysts in Birt–Hogg–Dubé Syndrome	10
Combined Pulmonary Fibrosis and Emphysema	9
Antimicrobial Stewardship in the ICU	9
Amyloid in the Lung	9
The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes	9
Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management	9
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease	9
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia	9
Update on Sepsis Epidemiology in the Era of COVID-19	9
Small Cell Lung Cancer: Advances in Diagnosis and Management	9
Familial Interstitial Lung Disease	9
Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock	8
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	8
Melioidosis: A Neglected Cause of Community-Acquired Pneumonia	8
Screening Sarcoidosis Patients for Occult Disease	8
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia	8
The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer	8
Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis	8
Endemic Fungi Presenting as Community-Acquired Pneumonia: A Review	8
Risk Stratification in Acute Pulmonary Embolism: The Latest Algorithms	8
Middle East Respiratory Syndrome Coronavirus	8
Radiographic and Histopathologic Features in Sarcoidosis: A Pictorial Display	8
Life-Threatening Hemoptysis	8
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	8
Fungal Infection in Lung Transplantation	8
Mechanical Ventilation for COVID-19 Patients	7
The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment	7
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	7
Which Biomarkers Can Be Used as Diagnostic Tools for Infection in Suspected Sepsis?	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	7
Acute Rejection in the Modern Lung Transplant Era	7
Nonspecific Interstitial Pneumonia	7
COVID-19 in Immunocompromised Patients: A Systematic Review	7
Pseudomonas aeruginosa in Bronchiectasis	7
Thoracic Involvement in IgG4-Related Disease	7
Antiviral Treatments for Influenza	7
Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era	7

Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19	6
VATS and Minimally Invasive Resection in Early-Stage NSCLC	6
Bronchiolitis and Bronchiolar Disorders	6
Pulmonary Alveolar Microlithiasis	6
Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Aspergillus-Associated Endophenotypes in Bronchiectasis	6
Invasive Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Exacerbations	6
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	6
Community-Acquired Pneumonia: A Global Perspective	6
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia	6
Glucocorticoid Therapy in COVID-19	5
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations	5
Respiratory Syncytial Virus	5
COVID-19 Vaccines—All You Want to Know	5
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management	5
Clinical and Radiological Phenotypes and Endotypes	5
Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant	5
Pulmonary Embolism in Pregnancy	5
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies	5
Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock	5
“Long Haulers”	5
Primary Graft Dysfunction	5
Nontuberculous Mycobacteria	5
Antibody-Mediated Rejection and Lung Transplantation	5
Lung Volume Reduction in Pulmonary Emphysema	5
End-of-Life Issues in Intensive Care Units	5